SARS
High-dose pulse corticosteroid treatment more effective than low-dose therapy
Published in TB and Outbreaks Week, February 3rd, 2004
According to a study from China, "The treatment of atypical pneumonia, subsequently termed severe acute respiratory syndrome (SARS), is controversial, and the efficacy of corticosteroid therapy is unknown."
To remedy this, J.C. Ho and colleagues at the University of Hong Kong "evaluated the clinical and radiographic outcomes of 72 patients with probable SARS (median age 37 years, 30 M), who received ribavirin and different steroid regimens in two regional hospitals."
"Chest radiographs were scored according to the percentage of lung field involved,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Collaborations
Alliance to develop, commercialize influenza vaccines - Correctional Health
Treatment in prison can prevent disease outside, says U.S. Surgeon General - Dengue Fever
Thailand epidemics have 3-year cycle - Diphtheria
Federal government report illustrates current diphtheria risks - Drug Development
Glycosylated beta-amino hydroxamates show promise as antimalarials - Drug Development
Novel 1beta-methylcarbapenems have potent antimicrobial activity - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
